Estimate The 10-Year Cardiovascular Risk In The General Public Of Hong Kong

7.6; 37% female, 63% male) participated in a health examination which included a lipid profi le. An index date was assigned for each study participant using the date of their exam and statin medication usage was determined through the pharmacy claims database for 365 days before the index date. Patients were identifi ed as adherent to statins if their medication possession ratio (MPR) was at least 80%. RESULTS: Statin use increased over the study period with 150 (9.3%) executives fi lling at least one statin prescription in the 365 days prior to their exam. A total of 102 statin users (68%) were adherent to statin medication. Among all patients who received statin treatment, 70% (OR 2.33, 95% CI 1.54, 3.51) achieved near optimal ( 130 mg/ dL) and 30% (OR 1.78, 95% CI 1.15, 2.76) achieved optimal ( 100 mg/dL) LDL-C goals which are signifi cantly higher than the rates among statin non-users (55% and 21%). Both adherent statin users and nonadherent statin users were more likely to achieve recommended near optimal LDL-C goals compared to executives who were not taking statins (overall p 0.002; adherent: OR 2.75, 95%CI 1.662, 4.550; nonadherent: OR 1.70, 95% CI 0.884, 3.268.) CONCLUSIONS: Among executives who participated in a periodic health examination, statin usage appears to be associated with improvements in LDL-C goal attainment. Appropriate medication usage and adherence to medication should be encouraged in working populations.